BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15530485)

  • 1. C-reactive protein concentrations are lower in Singaporeans: implications for risk classification in Asians.
    Hawkins RC
    Clin Chim Acta; 2004 Dec; 350(1-2):241-2. PubMed ID: 15530485
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipoprotein complexed C-reactive protein in patients with coronary heart disease.
    Elmas E; Kälsch T; Borggrefe M; Dempfle CE
    Thromb Haemost; 2005 Nov; 94(5):1111-2. PubMed ID: 16363260
    [No Abstract]   [Full Text] [Related]  

  • 3. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study.
    Cushman M; Arnold AM; Psaty BM; Manolio TA; Kuller LH; Burke GL; Polak JF; Tracy RP
    Circulation; 2005 Jul; 112(1):25-31. PubMed ID: 15983251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome and C-reactive protein among cardiology patients.
    Chapidze G; Dolidze N; Enquobahrie DA; Kapanadze S; Latsabidze N; Williams MA
    Arch Med Res; 2007 Oct; 38(7):783-8. PubMed ID: 17845899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers.
    Rothenbacher D; Brenner H; März W; Koenig W
    Eur Heart J; 2005 Aug; 26(16):1640-6. PubMed ID: 15932907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein in the prediction of cardiovascular and overall mortality in middle-aged men: a population-based cohort study.
    Laaksonen DE; Niskanen L; Nyyssönen K; Punnonen K; Tuomainen TP; Salonen JT
    Eur Heart J; 2005 Sep; 26(17):1783-9. PubMed ID: 15821003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of high sensitivity C-reactive protein in assessing the risk for coronary heart disease.
    Legrys VA
    Clin Lab Sci; 2001; 14(4):243-6. PubMed ID: 11760822
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease.
    Youssef MY; Mojiminiyi OA; Abdella NA
    Transl Res; 2007 Sep; 150(3):158-63. PubMed ID: 17761368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive correlation of CRP and fibrinogen levels as cardiovascular risk factors in early stage of continuous ambulatory peritoneal dialysis patients.
    Tekin IO; Pocan B; Borazan A; Ucar E; Kuvandik G; Ilikhan S; Demircan N; Ozer C; Kadayifci S
    Ren Fail; 2008; 30(2):219-25. PubMed ID: 18300125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary: Social class, C-reactive protein and coronary heart disease.
    Casas JP
    Int J Epidemiol; 2008 Apr; 37(2):299-300. PubMed ID: 18285367
    [No Abstract]   [Full Text] [Related]  

  • 11. C-reactive protein and coronary heart disease.
    Libby P; Willerson JT; Braunwald E
    N Engl J Med; 2004 Jul; 351(3):295-8; author reply 295-8. PubMed ID: 15257564
    [No Abstract]   [Full Text] [Related]  

  • 12. Should high sensitive C-reactive protein measurement be included in health screening packages?
    Hawkins RC; Leong L
    Singapore Med J; 2006 Oct; 47(10):837-40. PubMed ID: 16990957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein distribution and correlates among men and women with chronic coronary heart disease.
    Benderly M; Haim M; Boyko V; Tanne D; Behar S; Matas Z; Zimlichman R; Goldbourt U
    Cardiology; 2007; 107(4):345-53. PubMed ID: 17283424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of high sensitivity C-reactive protein in coronary artery disease risk prediction: a review.
    Abou Diwan CH; Oghlakian GO; Antonios SI; Otrock ZK; Rebeiz AG
    J Med Liban; 2004; 52(1):39-47. PubMed ID: 15881701
    [No Abstract]   [Full Text] [Related]  

  • 15. C-reactive protein in healthy and in sick populations.
    Danesh J; Pepys MB
    Eur Heart J; 2000 Oct; 21(19):1564-5. PubMed ID: 10988004
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of inflammation for heart disease risk cannot be determined by correlations between C-reactive protein and risk factors.
    Engström G
    Arch Intern Med; 2006 May; 166(9):1040; author reply 1040-1. PubMed ID: 16682580
    [No Abstract]   [Full Text] [Related]  

  • 17. [C-reactive protein in patients with coronary heart disease].
    Rajtar R; Kolasińska-Kloch W; Kloch M
    Folia Med Cracov; 2004; 45(1-2):25-32. PubMed ID: 16276823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.
    van der Harst P; Voors AA; Volbeda M; Buikema H; van Veldhuisen DJ; van Gilst WH
    Am J Cardiol; 2006 Jun; 97(12):1697-701. PubMed ID: 16765116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease.
    Rothenbacher D; Koenig W; Brenner H
    Arch Intern Med; 2006 Dec 11-25; 166(22):2455-60. PubMed ID: 17159010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein gene haplotypes and risk of coronary heart disease: the Rotterdam Study.
    Kardys I; de Maat MP; Uitterlinden AG; Hofman A; Witteman JC
    Eur Heart J; 2006 Jun; 27(11):1331-7. PubMed ID: 16682383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.